Functional categories associated with clusters of genes that are co-expressed across the NCI-60 cancer cell lines

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Zeeberg, Barry R ^a   Reinhold, William ^a   Snajder, René ^b   Thallinger, Gerhard G ^b   Weinstein, John N ^a,c   Kohn, Kurt W ^a   Pommier, Yves ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME; ANTINEOPLASTIC AGENT;

ANALYTICAL EQUIPMENT; ARTICLE; CANCER CELL; CELL ADHESION; CELL MIGRATION; CLASSIFICATION; CONSORTIUM DATABASE; CONTROLLED STUDY; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE MAPPING; GENE ONTOLOGY; GOMINER TOOL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; RNA SPLICING; SIGNAL TRANSDUCTION; ALGORITHM; CLUSTER ANALYSIS; COMPARATIVE STUDY; DRUG SCREENING; EVALUATION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETICS; HIGH THROUGHPUT SCREENING; ISOLATION AND PURIFICATION; METHODOLOGY; MULTIGENE FAMILY; NEOPLASM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ALGORITHMS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CLUSTER ANALYSIS; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENETIC ASSOCIATION STUDIES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MULTIGENE FAMILY; NEOPLASMS;

EID: 84856204554     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030317     Document Type: Article

References (26)

1. Holbeck S, Chang J, Best AM, Bookout AL, Mangelsdorf DJ, et al. (2010) Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions. Mol Endocrinol 24: 1287-1296.
2. Shoemaker RH, (2006) The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 6: 813-823.
3. Liu H, D'Andrade P, Fulmer-Smentek S, Lorenzi P, Kohn KW, et al. (2010) mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities. Mol Cancer Ther 9: 1080-1091.
4. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, et al. (2000) A gene expression database for the molecular pharmacology of cancer. Nat Genet 24: 236-244.
5. Shankavaram UT, Reinhold WC, Nishizuka S, Major S, Morita D, et al. (2007) Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther 6: 820-832.
6. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJ Jr, et al. (1997) An information-intensive approach to the molecular pharmacology of cancer. Science 275: 343-349.
7. Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, et al. (2003) GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 4: R28.
8. Zeeberg BR, Qin H, Narasimhan S, Sunshine M, Cao H, et al. (2005) High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics 6: 168.
9. (2006) The Gene Ontology (GO) project in 2006. Nucleic Acids Res 34: D322-326.
10. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
11. Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, et al. (2005) Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436: 117-122.
12. Prieto C, Risueno A, Fontanillo C, De las Rivas J, (2008) Human gene coexpression landscape: confident network derived from tissue transcriptomic profiles. PLoS One 3: e3911.
13. Choi JK, Yu U, Yoo OJ, Kim S, (2005) Differential coexpression analysis using microarray data and its application to human cancer. Bioinformatics 21: 4348-4355.
14. Liu H, Zeeberg BR, Qu G, Koru AG, Ferrucci A, et al. (2007) AffyProbeMiner: a web resource for computing or retrieving accurately redefined Affymetrix probe sets. Bioinformatics 23: 2385-2390.
15. Ryan MC, Zeeberg BR, Caplen NJ, Cleland JA, Kahn AB, et al. (2008) SpliceCenter: a suite of web-based bioinformatic applications for evaluating the impact of alternative splicing on RT-PCR, RNAi, microarray, and peptide-based studies. BMC Bioinformatics 9: 313.
16. Cho SB, Kim J, Kim JH, (2009) Identifying set-wise differential co-expression in gene expression microarray data. BMC Bioinformatics 10: 109.
17. Lai Y, Wu B, Chen L, Zhao H, (2004) A statistical method for identifying differential gene-gene co-expression patterns. Bioinformatics 20: 3146-3155.
18. Zoppoli G, Solier S, Reinhold WC, Liu H, Connelly JW Jr, et al. CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute. Oncogene.
19. Reinhold WC, Mergny JL, Liu H, Ryan M, Pfister TD, et al. (2010) Exon array analyses across the NCI-60 reveal potential regulation of TOP1 by transcription pausing at guanosine quartets in the first intron. Cancer Res 70: 2191-2203.
20. CellMiner.
21. Shankavaram UT, Varma S, Kane D, Sunshine M, Chary KK, et al. (2009) CellMiner: a relational database and query tool for the NCI-60 cancer cell lines. BMC Genomics 10: 277.
22. Wu Z, Irizarry RA, (2005) Stochastic models inspired by hybridization theory for short oligonucleotide arrays. J Comput Biol 12: 882-893.
23. Larsen RJ, Marx ML, (2000) An Introduction to Mathematical Statistics and Its Applications.
24. Eyre TA, Ducluzeau F, Sneddon TP, Povey S, Bruford EA, et al. (2006) The HUGO Gene Nomenclature Database, 2006 updates. Nucleic Acids Res 34: D319-321.
25. R Foundation for Statistical Computing Vienna, Austria.
26. Sturn A, Quackenbush J, Trajanoski Z, (2002) Genesis: cluster analysis of microarray data. Bioinformatics 18: 207-208.